Aerie Pharmaceuticals
AERI
#6054
Rank
C$1.08 B
Marketcap
$21.99
Share price
0.00%
Change (1 day)
98.07%
Change (1 year)

Revenue for Aerie Pharmaceuticals (AERI)

Revenue in 2022 (TTM): C$0.27 Billion

According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is C$0.30 Billion. In 2021 the company made a revenue of C$0.24 Billion an increase over the revenue in the year 2020 that were of C$0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aerie Pharmaceuticals from 2013 to 2022

20162019$50M$0.1B$0.15B$0.2B$0.25B$0.3B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2022 (TTM) C$0.27 B11.43%
2021 C$0.24 B133.39%
2020 C$0.10 B16.14%
2019 C$91.27 M177.11%
2018 C$32.93 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$0.49 B 60.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.54 M-97.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$91.10 B 29,428.70%๐Ÿ‡บ๐Ÿ‡ธ USA